Do you want to read an article? Please log in or register.
The microbiome in pancreatic diseases: Recent advances and future perspectives
Pancreas Diseases
Related content
Gastrointestinal Cancer
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
Lancet Oncol.
Christenson ES, Jaffee E, Azad NS
doi: 10.1016/S1470-2045(19)30795-8.
Inflammatory Bowel Disease
The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases
Am J Gastroenterol.
Knox NC, Forbes JD, Peterson CL, Van Domselaar G, Bernstein CN
doi: 10.14309/ajg.0000000000000305.
Gastrointestinal Cancer
Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis
United European Gastroenterol J.
Iglesia D, Avci B, Kiriukova M, Panic N, Bozhychko M, Sandru V, de-Madaria E, Capurso G
doi: 10.1177/2050640620938987.
Locally advanced gastro-oesophageal cancer: Recent therapeutic advances and research directions
Cancer Treat Rev.
Fornaro L, Vasile E, Aprile G, Goetze TO, Vivaldi C, Falcone A, Al-Batran SE
doi: 10.1016/j.ctrv.2018.06.012.
Hepatology
Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function
Gut
Frost F, Kacprowski T, Rühlemann M, Pietzner M, Bang C, Franke A, Nauck M, Völker U, Völzke H, Dörr M, Baumbach J, Sendler M, Schulz C, Mayerle J, Weiss FU, Homuth G, Lerch MM
doi: 10.1136/gutjnl-2020-322753
Gastrointestinal CancerPancreas Diseases
Risks and Characteristics of Pancreatic Cancer and Pancreatic Relapse in Autoimmune Pancreatitis Patients
J Gastroenterol Hepatol.
Ishikawa T, Kawashima H, Ohno E, Iida T, Suzuki H, Uetsuki K, Yamada K, Yashika J, Yoshikawa M, Gibo N, Aoki T, Kataoka K, Mori H, Fujishiro M
doi: 10.1111/jgh.15163.
Inflammatory Bowel Disease
Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease
Inflamm Bowel Dis.
Olaisen M, Flatberg A, Granlund AVB, Røyset ES, Martinsen TC, Sandvik AK, Fossmark R
doi: 10.1093/ibd/izaa107.
COMMENTED
Gallbladder and Biliary DiseasesHepatitisHepatology
Recent advances in clinical practice: epidemiology of autoimmune liver diseases
★ 2
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Gut
Trivedi PJ, Hirschfield GM
doi: 10.1136/gutjnl-2020-322362
Gastrointestinal Cancer
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
Lancet Gastroenterol Hepatol
Kunzmann V, Siveke JT, Algül H, Goekkurt E, Siegler G, Martens U, Waldschmidt D, Pelzer U, Fuchs M, Kullmann F, Boeck S, Ettrich TJ, Held S, Keller R, Klein I, Germer CT, Stein H, Friess H, Bahra M, Jakobs R, Hartlapp I, Heinemann V, German Pancreatic Cancer Working Group (AIO-PAK) and NEOLAP investigators.
doi: 10.1016/S2468-1253(20)30330-7